HIGHLIGHTS
- who: FGF and collaborators from the Department of Breast, General, Qilu of Shandong University, Jinan, China, Department of have published the article: Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate whether co-treatment with RES and FGF1 could protect against DOX-induced hepatocyte injury and to determine the roles of AMPK and NRF2 in the mechanism of this potential hepato-protective effect. This study provides multiple lines of evidence that cotreatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.